Cabaletta Bio Files 8-K on Corporate Actions
Ticker: CABA · Form: 8-K · Filed: Jun 10, 2025 · CIK: 1759138
Sentiment: neutral
Topics: corporate-governance, filing
TL;DR
Cabaletta Bio filed an 8-K on June 9th covering corporate changes and financial docs.
AI Summary
Cabaletta Bio, Inc. filed an 8-K on June 10, 2025, reporting on events that occurred on June 9, 2025. The filing primarily concerns amendments to its articles of incorporation or bylaws, submission of matters to a vote of security holders, and financial statements and exhibits. The company is incorporated in Delaware and headquartered in Philadelphia, PA.
Why It Matters
This 8-K filing indicates significant corporate governance and financial reporting activities for Cabaletta Bio, Inc., which could impact investor understanding of the company's structure and financial status.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain material adverse news.
Key Players & Entities
- Cabaletta Bio, Inc. (company) — Registrant
- June 9, 2025 (date) — Date of earliest event reported
- June 10, 2025 (date) — Date of Report
- Philadelphia, PA (location) — Principal executive offices
FAQ
What specific amendments were made to Cabaletta Bio's articles of incorporation or bylaws?
The filing indicates that amendments were made, but the specific details of these amendments are not provided in the summary information.
What matters were submitted to a vote of security holders?
The filing states that matters were submitted to a vote of security holders, but the nature of these matters is not detailed in the provided text.
What financial statements and exhibits are included in this filing?
The filing mentions the submission of financial statements and exhibits, but the specific content is not described in the provided summary.
When was Cabaletta Bio, Inc. incorporated and in which jurisdiction?
Cabaletta Bio, Inc. was incorporated in Delaware.
What is the business address and phone number for Cabaletta Bio, Inc.?
The business address is 2929 Arch Street, Suite 600, Philadelphia, PA 19104, and the phone number is (267) 759-3100.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 10, 2025 regarding Cabaletta Bio, Inc. (CABA).